Search results
Studies Reveal Cell-by-Cell Changes Caused When Pig Hearts and Kidneys are Transplanted into Humans
CBS 47 Fresno· 22 hours agoSurgical teams at NYU Langone Health performed the world's first genetically modified pig kidney transplants into a human body in September and November ...
Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront and up to...
Market Watch· 2 hours agoThe drug has received Breakthrough Therapy Designation and Orphan Drug Designation from the U.S....
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
WJET - WFXP Erie· 1 day agoImlifidase has conditional marketing approval in Europe under the trade name IDEFIRIX® for the...
‘She’s my hero’: Wife donates kidney to save husband’s life after he was diagnosed with rare disease
WIBW Topeka· 3 days agoA woman in Nashville donated one of her kidneys to her husband after he was diagnosed with a rare...
Q1 2024 OncoCyte Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoOur own research is breaking new ground in transplant. We see an opportunity for OncoCyte’s technology to improve transplant rejection
Xenotransplant Responses, Interactions Unraveled With Multiomic Analyses
GenomeWeb News· 5 days agoThe two pig heart xenografts were transplanted "with the primary aim of assessing the presence of hyperacute antibody-mediated rejection (AbMR) and sustained ...
OncoCyte Corp (OCX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
GuruFocus.com via Yahoo Finance· 6 days agoThe company has successfully initiated early commercialization efforts and is poised for unprecedented growth over the...12 to 18 months, driven by multiple milestones. OncoCyte Corp's technology ...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in...
WTRF Wheeling· 1 day agoDURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions ...